Recent Posts
- Lawsuit Prompts U.S. State Department To Strengthen Protections Of HIV-Positive Contract Workers
- San Francisco Postpones Agency Cuts, Los Angeles AIDS Clearinghouse Closes
- Kennedy’s Contributions To HIV/AIDS, Gay Rights Policies Recalled
- Routine Circumcision Does Not Protect Against HIV For Men Who Have Sex With Men, CDC Study Finds
- NBA Legend Dikembe Mutombo, UNICEF Executive Director Ann M. Veneman And BD Commemorate Opening Of New Center To Improve HIV/AIDS Treatment In The DRC
Random Posts
- Federal Officials To Study New Strategy To Boost HIV Testing, Treatment
- World Bank HIV/AIDS Programs Less Effective Than Its Other Health Programs, Report Finds
- Medical Center Researchers Honored For Excellence
- California HIV Services Center Forced To Close
- Young People With Disabilities In Botswana Call For Greater Involvement In Country's HIV/AIDS Efforts
- Genetic, Geographic Data Deliver Clear Picture Of HIV Progress, Explaining HIV Spread In Central And East Africa
- Globe And Mail Examines HIV/AIDS Rate In India
- Risk Of HIV Transmission Heightened By Risky Sexual Behavior Among Male Clients Of Tijuana Sex Workers
- New Issue Of MAMBO Magazine Raises Questions About Faith And Sexual Health
- No-Entry Zones For AIDS Virus
Prescription AIDS Drugs
Contact Us
Recent disruptions in the supply of anti-retroviral (ARV) drugs and other essential medical items in at least six African countries are putting HIV patients’ lives at risk, said the international medical humanitarian organization Doctors Without Borders/Medecins Sans Frontières (MSF) today, in advance of the International AIDS Society Conference in Cape Town, South Africa.
Funding gaps and supply management problems have led to the delay, suspension-or risk of suspension-of the supply of life-saving HIV drugs in recent months. The inaction of national governments, donors, and their partners must end and they must take urgent and concrete measures, said MSF.
The consequences of disruptions in funding and supplies are potentially catastrophic: if the start of new patients on treatment has to be suspended or delayed, then the lives of many in urgent need of drugs are at risk. For people already on treatment, the interruptions or lowering of dosages will lead to treatment failure and a higher risk of developing drug-resistance. Disruptions are having a direct impact on MSF’s HIV programs.
In South Africa, the government budget for health was cut due to the global financial crisis; finding alternative funding seems difficult in the short term.
“All around us, clinics stop enrolling patients because there are just not enough ARV supplies,” said Eric Goemaere, MSF head of mission in South Africa. “The waiting lists are growing by the day, risking that patients die before they start ARVs. It’s unbelievable that a relatively well-functioning ARV program has been allowed to be crippled in the space of just a few weeks. MSF will not be able to fill the gaps, and we seriously question why we should have to do so, in view of declared international commitments.”
In Malawi, delays in funding disbursements from the Global Fund for AIDS, Tuberculosis and Malaria have already caused worrying shortages in ARV supplies. As a result, ARV stocks are running dangerously low in several health facilities. In order to avoid further ruptures, the Ministry of Health, with the help of MSF and other NGOs, is currently re-distributing ARV supplies to different districts. MSF has also had to buy additional backup stocks, to ensure a steady supply for patients in its projects. For now, MSF is able to start new patients on treatment, but there is a real risk that this will have to slow down.
MSF teams in Uganda, the Democratic Republic of Congo, Zimbabwe, and Guinea are also seeing stock-outs and disruptions.
Disruptions are a result of a shortage of in-country funding and delays by donor governments in fulfilling their commitments. Major international funding institutions such as the Global Fund for AIDS, tuberculosis and malaria and PEPFAR face budget caps or uncertainty in the replenishment of funding. Country level supply management and procurement issues compound the problem, as any delays in funding place the supply chain in danger.
“MSF is extremely concerned about the lack of effective action from governments, their partners, and international donors in assuring the continued funding and supply of ARVs and other medical items for treatment,” said Meinie Nicolai, MSF director of operations. “They are playing with fire: no ARVs means no HIV/AIDS treatment. Governments and donors must respond to funding and supply problems urgently and effectively.”
Source
Doctors Without Borders
Related posts:
- Funding Cut To North Carolina ADAP Should Not Affect Patients, Officials Say Patient / Public: Health Professional: Article Opinions: 0 posts...
- New HIV Recommendations To Improve Health, Reduce Infections And Save Lives On the eve of World AIDS Day, the World Health...
- Uganda’s Health Ministry Orders Investigations Into Deaths Of Patients Living With HIV Patient / Public: Health Professional: Article Opinions: ...
- Certain Cancers More Common Among HIV Patients Than Non-HIV Patients Researchers at UT Southwestern Medical Center have found that non-AIDS-defining...
- AIDS Patients With Serious Complications Benefit From Early Retroviral Use, Stanford Study Shows HIV-positive patients who don’t seek medical attention until they have...
Related posts brought to you by Yet Another Related Posts Plugin.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.